<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37134326</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-4141</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of immunology</Title><ISOAbbreviation>Eur J Immunol</ISOAbbreviation></Journal><ArticleTitle>T-bet-expressing B cells contribute to the autoreactive plasma cell pool in Lyn<sup>-/-</sup> mice.</ArticleTitle><Pagination><StartPage>e2250300</StartPage><MedlinePgn>e2250300</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/eji.202250300</ELocationID><Abstract><AbstractText>Systemic Lupus Erythematosus (SLE) is characterized by pathogenic autoantibodies against nucleic acid-containing antigens. Understanding which B-cell subsets give rise to these autoantibodies may reveal therapeutic approaches for SLE that spare protective responses. Mice lacking the tyrosine kinase Lyn, which limits B and myeloid cell activation, develop lupus-like autoimmune diseases characterized by increased autoreactive plasma cells (PCs). We used a fate-mapping strategy to determine the contribution of T-bet<sup>+</sup> B cells, a subset thought to be pathogenic in lupus, to the accumulation of PCs and autoantibodies in Lyn<sup>-/-</sup> mice. Approximately, 50% of splenic PCs in Lyn<sup>-/-</sup> mice originated from T-bet<sup>+</sup> cells, a significant increase compared to WT mice. In vitro, splenic PCs derived from T-bet<sup>+</sup> B cells secreted both IgM and IgG anti-dsDNA antibodies. To determine the role of these cells in autoantibody production in vivo, we prevented T-bet<sup>+</sup> B cells from differentiating into PCs or class switching in Lyn<sup>-/-</sup> mice. This resulted in a partial reduction in splenic PCs and anti-dsDNA IgM and complete abrogation of anti-dsDNA IgG. Thus, T-bet<sup>+</sup> B cells make an important contribution to the autoreactive PC pool in Lyn<sup>-/-</sup> mice.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ottens</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Jalyn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satterthwaite</LastName><ForeName>Anne B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, UT Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AI137746</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI161307</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI161307</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI137746</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Immunol</MedlineTA><NlmUniqueID>1273201</NlmUniqueID><ISSNLinking>0014-2980</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D019061">src-Family Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="C060902">lyn protein-tyrosine kinase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010950" MajorTopicYN="Y">Plasma Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019061" MajorTopicYN="N">src-Family Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lyn</Keyword><Keyword MajorTopicYN="N">T-bet</Keyword><Keyword MajorTopicYN="N">autoantibody</Keyword><Keyword MajorTopicYN="N">lupus</Keyword><Keyword MajorTopicYN="N">plasma cell</Keyword></KeywordList><CoiStatement>Conflict of Interest Disclosure. The authors declare no financial or commercial conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37134326</ArticleId><ArticleId IdType="mid">NIHMS1902896</ArticleId><ArticleId IdType="pmc">PMC10524956</ArticleId><ArticleId IdType="doi">10.1002/eji.202250300</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu Z, and Davidson A. 2012. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 18: 871&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3607103</ArticleId><ArticleId IdType="pubmed">22674006</ArticleId></ArticleIdList></Reference><Reference><Citation>Atisha-Fregoso Y, Toz B, and Diamond B. 2021. Meant to B: B cells as a therapeutic target in systemic lupus erythematosus. J Clin Invest 131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8203443</ArticleId><ArticleId IdType="pubmed">34128474</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Harder KW, Huntington ND, Hibbs ML, and Tarlinton DM. 2005. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22: 9&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">15664155</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, and Dunn AR. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83: 301&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">7585947</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, and Yamamoto T. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3: 549&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">7584145</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan VW, Meng F, Soriano P, DeFranco AL, and Lowell CA. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7: 69&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">9252121</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez T, Halcomb KE, Coughran AJ, Li QZ, and Satterthwaite AB. 2010. Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn-deficient mice. Eur J Immunol 40: 1897&#x2013;1905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3057185</ArticleId><ArticleId IdType="pubmed">20394076</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsantikos E, Oracki SA, Quilici C, Anderson GP, Tarlinton DM, and Hibbs ML. 2010. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6. J Immunol 184: 1348&#x2013;1360.</Citation><ArticleIdList><ArticleId IdType="pubmed">20042579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamagna C, Hu Y, DeFranco AL, and Lowell CA. 2014. B cell-specific loss of Lyn kinase leads to autoimmunity. J Immunol 192: 919&#x2013;928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900234</ArticleId><ArticleId IdType="pubmed">24376269</ArticleId></ArticleIdList></Reference><Reference><Citation>Liossis SN, Solomou EE, Dimopoulos MA, Panayiotidis P, Mavrikakis MM, and Sfikakis PP. 2001. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J Investig Med 49: 157&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">11288756</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Borja F, Kabouridis PS, Jury EC, Isenberg DA, and Mageed RA. 2005. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 52: 3955&#x2013;3965.</Citation><ArticleIdList><ArticleId IdType="pubmed">16320343</ArticleId></ArticleIdList></Reference><Reference><Citation>International Consortium for Systemic Lupus Erythematosus, G., Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD, Nath SK, Guthridge JM, Cobb BL, Mirel DB, Marion MC, Williams AH, Divers J, Wang W, Frank SG, Namjou B, Gabriel SB, Lee AT, Gregersen PK, Behrens TW, Taylor KE, Fernando M, Zidovetzki R, Gaffney PM, Edberg JC, Rioux JD, Ojwang JO, James JA, Merrill JT, Gilkeson GS, Seldin MF, Yin H, Baechler EC, Li QZ, Wakeland EK, Bruner GR, Kaufman KM, and Kelly JA. 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712260</ArticleId><ArticleId IdType="pubmed">18204446</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Vidal GS, Kelly JA, Delgado-Vega AM, Howard XK, Macwana SR, Dominguez N, Klein W, Burrell C, Harley IT, Kaufman KM, Bruner GR, Moser KL, Gaffney PM, Gilkeson GS, Wakeland EK, Li QZ, Langefeld CD, Marion MC, Divers J, Alarcon GS, Brown EE, Kimberly RP, Edberg JC, Ramsey-Goldman R, Reveille JD, McGwin G Jr., Vila LM, Petri MA, Bae SC, Cho SK, Bang SY, Kim I, Choi CB, Martin J, Vyse TJ, Merrill JT, Harley JB, Alarcon-Riquelme ME, Biolupus GM Collaborations, Nath SK, James JA, and Guthridge JM. 2009. Genetic associations of LYN with systemic lupus erythematosus. Genes Immun 10: 397&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2750001</ArticleId><ArticleId IdType="pubmed">19369946</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjarrez-Orduno N, Marasco E, Chung SA, Katz MS, Kiridly JF, Simpfendorfer KR, Freudenberg J, Ballard DH, Nashi E, Hopkins TJ, Cunninghame Graham DS, Lee AT, Coenen MJ, Franke B, Swinkels DW, Graham RR, Kimberly RP, Gaffney PM, Vyse TJ, Behrens TW, Criswell LA, Diamond B, and Gregersen PK. 2012. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet 44: 1227&#x2013;1230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715052</ArticleId><ArticleId IdType="pubmed">23042117</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, Mayeux J, Gutierrez T, Russell L, Getahun A, Muller J, Tedder T, Parnes J, Rickert R, Nitschke L, Cambier J, Satterthwaite AB, and Garrett-Sinha LA. 2014. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels. J Immunol 193: 909&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4082765</ArticleId><ArticleId IdType="pubmed">24929000</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeux J, Skaug B, Luo W, Russell LM, John S, Saelee P, Abbasi H, Li QZ, Garrett-Sinha LA, and Satterthwaite AB. 2015. Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels. J Immunol 195: 1955&#x2013;1963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4546901</ArticleId><ArticleId IdType="pubmed">26209625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez T, Mayeux JM, Ortega SB, Karandikar NJ, Li QZ, Rakheja D, Zhou XJ, and Satterthwaite AB. 2013. IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn&#x2212;/&#x2212; mice. Eur J Immunol 43: 382&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3768150</ArticleId><ArticleId IdType="pubmed">23169140</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouat IC, Goldberg E, and Horwitz MS. 2022. Age-associated B cells in autoimmune diseases. Cell Mol Life Sci 79: 402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9263041</ArticleId><ArticleId IdType="pubmed">35798993</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW, and Marrack P. 2011. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity. Blood 118: 1305&#x2013;1315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3152497</ArticleId><ArticleId IdType="pubmed">21543762</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, Rubtsova K, Kappler JW, and Marrack P. 2013. TLR7 drives accumulation of ABCs and autoantibody production in autoimmune-prone mice. Immunol Res 55: 210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3935605</ArticleId><ArticleId IdType="pubmed">22945807</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, Rubtsov AV, van Dyk LF, Kappler JW, and Marrack P. 2013. T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance. Proc Natl Acad Sci U S A 110: E3216&#x2013;3224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3752276</ArticleId><ArticleId IdType="pubmed">23922396</ArticleId></ArticleIdList></Reference><Reference><Citation>Naradikian MS, Myles A, Beiting DP, Roberts KJ, Dawson L, Herati RS, Bengsch B, Linderman SL, Stelekati E, Spolski R, Wherry EJ, Hunter C, Hensley SE, Leonard WJ, and Cancro MP. 2016. Cutting Edge: IL-4, IL-21, and IFN-gamma Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells. J Immunol 197: 1023&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4975960</ArticleId><ArticleId IdType="pubmed">27430719</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, Tomar D, Woodruff MC, Simon Z, Bugrovsky R, Blalock EL, Scharer CD, Tipton CM, Wei C, Lim SS, Petri M, Niewold TB, Anolik JH, Gibson G, Lee FE, Boss JM, Lund FE, and Sanz I. 2018. Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Immunity 49: 725&#x2013;739 e726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6217820</ArticleId><ArticleId IdType="pubmed">30314758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Wang J, Kumar V, Karnell JL, Naiman B, Gross PS, Rahman S, Zerrouki K, Hanna R, Morehouse C, Holoweckyj N, Liu H, Autoimmunity Molecular Medicine T, Manna Z, Goldbach-Mansky R, Hasni S, Siegel R, Sanjuan M, Streicher K, Cancro MP, Kolbeck R, and Ettinger R. 2018. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE. Nat Commun 9: 1758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5931508</ArticleId><ArticleId IdType="pubmed">29717110</ArticleId></ArticleIdList></Reference><Reference><Citation>Manni M, Gupta S, Ricker E, Chinenov Y, Park SH, Shi M, Pannellini T, Jessberger R, Ivashkiv LB, and Pernis AB. 2018. Regulation of age-associated B cells by IRF5 in systemic autoimmunity. Nat Immunol 19: 407&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6095139</ArticleId><ArticleId IdType="pubmed">29483597</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, Rubtsov AV, Thurman JM, Mennona JM, Kappler JW, and Marrack P. 2017. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest 127: 1392&#x2013;1404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373868</ArticleId><ArticleId IdType="pubmed">28240602</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell Knode LM, Naradikian MS, Myles A, Scholz JL, Hao Y, Liu D, Ford ML, Tobias JW, Cancro MP, and Gearhart PJ. 2017. Age-Associated B Cells Express a Diverse Repertoire of VH and Vkappa Genes with Somatic Hypermutation. J Immunol 198: 1921&#x2013;1927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5322232</ArticleId><ArticleId IdType="pubmed">28093524</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumaquero E, Stone SL, Scharer CD, Jenks SA, Nellore A, Mousseau B, Rosal-Vela A, Botta D, Bradley JE, Wojciechowski W, Ptacek T, Danila MI, Edberg JC, Bridges SL Jr., Kimberly RP, Chatham WW, Schoeb TR, Rosenberg AF, Boss JM, Sanz I, and Lund FE. 2019. IFNgamma induces epigenetic programming of human T-bet(hi) B cells and promotes TLR7/8 and IL-21 induced differentiation. Elife 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6544433</ArticleId><ArticleId IdType="pubmed">31090539</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SW, Jacobs HM, Arkatkar T, Dam EM, Scharping NE, Kolhatkar NS, Hou B, Buckner JH, and Rawlings DJ. 2016. B cell IFN-gamma receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med 213: 733&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4854732</ArticleId><ArticleId IdType="pubmed">27069113</ArticleId></ArticleIdList></Reference><Reference><Citation>Du SW, Arkatkar T, Jacobs HM, Rawlings DJ, and Jackson SW. 2019. Generation of functional murine CD11c(+) age-associated B cells in the absence of B cell T-bet expression. Eur J Immunol 49: 170&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6779321</ArticleId><ArticleId IdType="pubmed">30353919</ArticleId></ArticleIdList></Reference><Reference><Citation>Chodisetti SB, Fike AJ, Domeier PP, Singh H, Choi NM, Corradetti C, Kawasawa YI, Cooper TK, Caricchio R, and Rahman ZSM. 2020. Type II but Not Type I IFN Signaling Is Indispensable for TLR7-Promoted Development of Autoreactive B Cells and Systemic Autoimmunity. J Immunol 204: 796&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7002260</ArticleId><ArticleId IdType="pubmed">31900342</ArticleId></ArticleIdList></Reference><Reference><Citation>Scapini P, Hu Y, Chu CL, Migone TS, Defranco AL, Cassatella MA, and Lowell CA. 2010. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J Exp Med 207: 1757&#x2013;1773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916124</ArticleId><ArticleId IdType="pubmed">20624892</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad R, Lanjuin A, Madisen L, Zeng H, Murthy VN, and Uchida N. 2013. Olfactory cortical neurons read out a relative time code in the olfactory bulb. Nat Neurosci 16: 949&#x2013;957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3695490</ArticleId><ArticleId IdType="pubmed">23685720</ArticleId></ArticleIdList></Reference><Reference><Citation>Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, and Zeng H. 2010. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13: 133&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840225</ArticleId><ArticleId IdType="pubmed">20023653</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng SL, Szabo SJ, and Glimcher LH. 2002. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc Natl Acad Sci U S A 99: 5545&#x2013;5550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122806</ArticleId><ArticleId IdType="pubmed">11960012</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein U, Casola S, Cattoretti G, Shen Q, Lia M, Mo T, Ludwig T, Rajewsky K, and Dalla-Favera R. 2006. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 7: 773&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pubmed">16767092</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis SN, Good-Jacobson KL, Curtis J, Light A, Tellier J, Shi W, Smyth GK, Tarlinton DM, Belz GT, Corcoran LM, Kallies A, and Nutt SL. 2014. Transcription factor IRF4 regulates germinal center cell formation through a B cell-intrinsic mechanism. J Immunol 192: 3200&#x2013;3206.</Citation><ArticleIdList><ArticleId IdType="pubmed">24591370</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook SL, Sievert EP, and Sciammas R. 2021. B Cell-Intrinsic IRF4 Haploinsufficiency Impairs Affinity Maturation. J Immunol 207: 2992&#x2013;3003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9085970</ArticleId><ArticleId IdType="pubmed">34759017</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza A, Yewdell WT, Hoyos B, Schizas M, Bou-Puerto R, Michaels AJ, Brown CC, Chaudhuri J, and Rudensky AY. 2021. Assembly of a spatial circuit of T-bet-expressing T and B lymphocytes is required for antiviral humoral immunity. Sci Immunol 6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8418793</ArticleId><ArticleId IdType="pubmed">34117110</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo S, Buckler J, and Erikson J. 2001. Novel roles for Lyn in B cell migration and lipopolysaccharide responsiveness revealed using anti-double-stranded DNA Ig transgenic mice. J Immunol 166: 3710&#x2013;3716.</Citation><ArticleIdList><ArticleId IdType="pubmed">11238611</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenks SA, Cashman KS, Woodruff MC, Lee FE, and Sanz I. 2019. Extrafollicular responses in humans and SLE. Immunol Rev 288: 136&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6422038</ArticleId><ArticleId IdType="pubmed">30874345</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone SL, Peel JN, Scharer CD, Risley CA, Chisolm DA, Schultz MD, Yu B, Ballesteros-Tato A, Wojciechowski W, Mousseau B, Misra RS, Hanidu A, Jiang H, Qi Z, Boss JM, Randall TD, Brodeur SR, Goldrath AW, Weinmann AS, Rosenberg AF, and Lund FE. 2019. T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-gamma on B Cells. Immunity 50: 1172&#x2013;1187 e1177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6929688</ArticleId><ArticleId IdType="pubmed">31076359</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Yao J, Zhao Y, Wang J, and Qi H. 2022. Heterogeneous plasma cells and long-lived subsets in response to immunization, autoantigen and microbiota. Nat Immunol 23: 1564&#x2013;1576.</Citation><ArticleIdList><ArticleId IdType="pubmed">36316480</ArticleId></ArticleIdList></Reference><Reference><Citation>Tominaga N, Ohkusu-Tsukada K, Udono H, Abe R, Matsuyama T, and Yui K. 2003. Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4. Int Immunol 15: 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12502720</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahnke J, Schumacher V, Ahrens S, Kading N, Feldhoff LM, Huber M, Rupp J, Raczkowski F, and Mittrucker HW. 2016. Interferon Regulatory Factor 4 controls TH1 cell effector function and metabolism. Sci Rep 6: 35521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5071867</ArticleId><ArticleId IdType="pubmed">27762344</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinen AP, Wanke F, Moos S, Attig S, Luche H, Pal PP, Budisa N, Fehling HJ, Waisman A, and Kurschus FC. 2014. Improved method to retain cytosolic reporter protein fluorescence while staining for nuclear proteins. Cytometry A 85: 621&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">24616430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottens K, Schneider J, Kane LP, and Satterthwaite AB. 2020. PIK3IP1 Promotes Extrafollicular Class Switching in T-Dependent Immune Responses. J Immunol 205: 2100&#x2013;2108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7541772</ArticleId><ArticleId IdType="pubmed">32887751</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>